The smallpox vaccine: An update for oral health care professionals

Journal of the American Dental Association

Volumn 137, Issue 4, 2006, Pages 452-460

  Rinaggio, Joseph ^a   Glick, Michael ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Bioterrorism; Dental management; Smallpox vaccine; Vaccinia virus; Variola

Indexed keywords

EID: 33646383624     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2006.0216     Document Type: Article

References (53)

1. Janoff EN, Lynfield R. Smallpox: remembrance of things past, or the coming plague? J Lab Clin Med 2003;142:211-5.
2. Hull HF, Danila R, Ehresmann K. Smallpox and bioterrorism: public-health responses. J Lab Clin Med 2003;142:221-8.
3. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281:2127-37.
4. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002;346:1300-8.
5. Eyler JM. Smallpox in history: the birth, death, and impact of a dread disease. J Lab Clin Med 2003;142:216-20.
6. Stearn EW, Stearn AE. The effect of smallpox on the destiny of the Amerindian. Boston: Bruce Humphries; 1945.
7. Kiang KM, Krathwohl MD. Rates and risks of transmission of smallpox and mechanisms of prevention. J Lab Clin Med 2003;142:229-38.
8. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva, Switzerland: World Health Organization; 1988.
9. Baron S. Smallpox: the main site of transmission is the oropharynx. J Dent Res 2003;82:252.
10. Barquet N, Domingo P. Smallpox: the triumph over the most terrible ministers of death (published correction appears in Ann Intern Med 1998;128:787). Ann Intern Med 1997;127:635-42.
11. World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980;55:145-52.
12. Bonilla-Guerrero R, Poland GA. Smallpox vaccines: current and future. J Lab Clin Med 2003;142:252-7.
13. Centers for Disease Control and Prevention. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 2003;52(RR-7):1-16.
14. Bennett ME, Ledell K. Current infection-control issues for smallpox disease and vaccinia vaccine. J Lab Clin Med 2003;142:239-45.
15. Massoudi MS, Barker L, Schwartz B. Effectiveness of postexposure vaccination for the prevention of smallpox: results of a delphi analysis. J Infect Dis 2003;188:973-6.
16. Centers for Disease Control and Prevention. Frequently asked questions about smallpox vaccine. Atlanta: Centers for Disease Control and Prevention, 2003. Available at: "www.bt.cdc.gov/agent/smallpox/vaccination/faq. asp". Accessed Oct. 22, 2004.
17. Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003;9:1131-7.
18. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003:171:4969-73.
19. Hatakeyama S, Moriya K, Saijo M, et al. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations. Clin Diagn Lab Immunol 2005;12:520-4.
20. Talbot TR, Stapleton JT, Brady RC, et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 2004;292:1205-12.
21. Erratum in: JAMA 2004;292:2470.
22. Kemper AR, Davis MM, Freed GL. Expected adverse events in a mass smallpox vaccination campaign. Eff Clin Pract 2002;5(2):84-90.
23. Centers for Disease Control and Prevention (CDC). Update: cardiac-related events during the civilian smallpox vaccination program-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:492-6.
24. Centers for Disease Control and Prevention (CDC). Update: cardiac and other adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:639-42.
25. Centers for Disease Control and Prevention (CDC). Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003;52:282-4.
26. Thorpe LE, Mostashari F, Karpati AM, et al. Mass smallpox vaccination and cardiac deaths, New York City, 1947. Emerg Infect Dis 2004;10:917-20.
27. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of 10 statewide surveys. J Infect Dis 1970;122:303-9.
28. Grabenstein JD, Winkenwerder W Jr. US military smallpox vaccination program experience. JAMA 2003;289:3278-82.
29. Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005;294:2734-43.
30. Lesho EP, Schissel DJ, Harris MD. Vaccinating health care workers against smallpox in an isolated primary care facility. Am J Med 2003;115:570-2.
31. Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions: guide for clinicians. MMWR Morb Mortal Wkly Rep 2003;52(RR-4):1-28.
32. Naleway AL, Belongia EA, Greenlee RT, Kieke BA Jr, Chen RT, Shay DK. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med 2003;139(1):1-7.
33. Kempe CH. Studies on smallpox and complications of smallpox vaccination. Pediatrics 1960;26(August):176-89.
34. Booss J, Davis LE. Smallpox and smallpox vaccination: neurological implications. Neurology 2003;60:1241-5.
35. Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 2005;294:2744-50.
36. Erratum in: JAMA 2005;294:3092.
37. Bray M, Wright ME. Progressive vaccinia. Clin Infect Dis 2003;36:766-74.
38. Goldstein JA, Neff JM, Lane JM, Koplan JP. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics 1975;55:342-7.
39. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 2004;43:1503-10.
40. Bartlett J, Borio L, Radonovich L, et al. Smallpox vaccination in 2003: key information for clinicians. Clin Infect Dis 2003;36:883-902.
41. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ 2003;52(SS-1):1-24.
42. Erratum in: MMWR Morb Mortal Wkly Rep 2003;52(6):113.
43. Bray M. Pathogenesis and potential antiviral therapy of complications of smallpox vaccination. Antiviral Res 2003;58(2):101-14.
44. Kempe CH, Berge TO, England B. Hyperimmune vaccinal gamma globulin: source, evaluation, and use in prophylaxis and therapy. Pediatrics 1956;18(2):177-88.
45. Painter GR, Hostetler KY. Design and development of oral drugs for the prophylaxis and treatment of smallpox infection. Trends Biotechnol 2004;22:423-7.
46. Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004;428(6979):182-5.
47. Drexler I, Staib C, Kastenmüller W, et al. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc Natl Acad Sci U S A 2003;100:217-22.
48. McCurdy LH, Larkin BD, Martin JE, Graham BS. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. Clin Infect Dis 2004;38:1749-53.
49. Harrison SC, Alberts B, Ehrenfeld E, et al. Discovery of antivirals against smallpox. Proc Natl Acad Sci U S A 2004;101:11178-92.
50. Guay AH. Dentistry's response to bioterrorism: a report of a consensus workshop. JADA 2002;133:1181-7.
51. Flores S, Mills SE, Shackleford L. Dentistry and bioterrorism. Dent Clin North Am 2003;47:733-44.
52. Han SZ, Alfano MC, Psoter WJ, Rekow ED. Bioterrorism and catastrophe response: a quick-reference guide to resources. JADA 2003:134:745-52.
53. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001;50(RR-10):1-25.